General Disclosures

  • 2022-03-01
    Julphar Announcements Regarding Unclaimed Cash Dividends of Shareholders | 0.28062 MB
  • 2022-02-10
    Board Meeting Results held on 10/02/2022 at 10:00 | 0.44292 MB
  • 2022-02-05
    Gulf Pharmaceutical Industries Announcement of Board Meeting to be held on 10/02/2022 at 10:00 | 0.43867 MB
  • 2021-12-06
    Julphar signs an exclusive license and production agreement with Quantum Genomics | 0.51178 MB
  • 2021-11-28
    Gulf Pharmaceutical Industries accumulated losses recovery report | 1.24583 MB
  • 2021-11-11
    Press Release on the Financial Results for the Period Ended September 30,2021 | 0.33538 MB
This website intends to use cookies to improve the site and your experience. By continuing to browse the site you are agreeing to accept our use of cookies. If you require further information and/or do not wish to have cookies placed when using the site, refer to our Cookie Policy.